Main menu

Genomic analysis of germline and somatic lesions at the FCGR locus; from reference genomes to clinicobiological implications


Monoclonal antibody (mAb) immunotherapy is becoming standard in the treatment of cancer, particularly for B-cell lymphoma patients. However responses are variable and relapse is common, thus the molecular mechanisms that underpin resistance need to be defined. mAbs interact with the Fc gamma receptors (FcγRs), a family of cell surface molecules crucial in the immune response. Human cells express six FcγRs: the high-affinity FcγRI and 5 low-affinity receptors which have both activatory (FcγRIIa, FcγRIIc, FcγRIIIa and FcγRIIIb) and inhibitory (FcγRIIb) capabilities.

Download the PDF

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag